Cite
MLA Citation
Veronica Asnaghi et al.. “[O2–17–06]: SAFETY AND TOLERABILITY OF CRENEZUMAB IN MILD‐TO‐MODERATE AD PATIENTS TREATED WITH ESCALATING DOSES FOR UP TO 25 MONTHS.” Alzheimer's & dementia, vol. 13, n.d., p. P602. http://access.bl.uk/ark:/81055/vdc_100103407991.0x00001d